ACB (Aurora Cannabis Inc. Common Shares) Stock Analysis - Insider Trades

Aurora Cannabis Inc. Common Shares (ACB) is a publicly traded Healthcare sector company. As of May 21, 2026, ACB trades at $3.48 with a market cap of $193.94M and a P/E ratio of 0.00. ACB moved +5.30% today. Year to date, ACB is -18.93%; over the trailing twelve months it is -35.02%. Its 52-week range spans $3.07 to $6.91. Rallies surfaces ACB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ACB stock inside the company?

Rallies tracks ACB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

ACB Key Metrics

Key financial metrics for ACB
MetricValue
Price$3.48
Market Cap$193.94M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.16%
52-Week High$6.91
52-Week Low$3.07
Volume2.16K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ACB News

ACB Analyst Consensus

ACB analyst coverage data. Average price target: $0.00.

Common questions about ACB

Who is trading ACB stock inside the company?
Rallies tracks ACB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for ACB?
Yes. Rallies tracks ACB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ACB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ACB. It does not provide personalized investment advice.
ACB

ACB